Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

In a rat 28-day oral gavage study conducted using a protocol similar to OECD 407 and to GLP (Huntingdon Research Centre, 1988) the NOAEL for triethoxyisobutylsilane was at least 1000 mg/kg bw/day, as there were no adverse toxicological findings at this the only dose tested. 
In a repeated nose-only inhalation study, conducted to OECD 413 and to GLP (Safepharm Laboratories, Ltd., 1992) the NOAEC for triethoxyisobutylsilane was at least 2.54 mg/l in rats.
There are no dermal data.

Key value for chemical safety assessment

Repeated dose toxicity: via oral route - systemic effects

Endpoint conclusion
Dose descriptor:
NOAEL
1 000 mg/kg bw/day
Study duration:
subacute
Species:
rat

Repeated dose toxicity: inhalation - systemic effects

Endpoint conclusion
Dose descriptor:
NOAEC
2 540 mg/m³
Study duration:
subchronic
Species:
rat

Additional information

The key and supporting studies for triethoxyisobutylsilane show that this substance has a low potential to cause adverse health effects.

Justification for classification or non-classification

Based on the available oral and inhalation repeated dose toxicity studies, triethoxyisobutylsilane is not classified for specific target organ toxicity following repeated exposure according to Regulation 1272/2008/EC.